Sanofi to Merge European API Plants into Separate Major API Company
Sanofi to Merge European API Plants into Separate Major API Company
GALWAY, IRELAND--March 4, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--French pharmaceutical major Sanofi has announced plans to spin off six of its active pharmaceutical ingredients (API) manufacturing sites in Europe into one , large standalone API producer.
Within this article: Details proposed spin-off, estimated sales, impact on global API production, Coronavirus impact on current manufacturing
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Sanofi Investing Big in New French Vaccine Plants
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- Chemicals, Pharma-Biotech Take Spotlight in Pennsylvania's $31 Billion of A...
- Tetra Tech at Work on More than $18.8 Billion in U.S. Projects